EOSINOPHILIC ASTHMA
Clinical trials for EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental asthma pill shows promise, but study halted early
Disease control TerminatedThis study tested an oral drug called dexpramipexole in over 1,000 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce serious asthma attacks over 52 weeks when added to standard…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Asthma drug safety check ends early: what we know
Disease control TerminatedThis study aimed to check the long-term safety of the drug dexpramipexole in adults with severe eosinophilic asthma. It included 509 people who had already finished a previous phase 3 study. The trial was terminated early, so results are limited.
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
Asthma drug trial halted midway: what happened?
Disease control TerminatedThis study tested a daily pill called dexpramipexole in 654 people with severe eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. The goal was to see if the drug could reduce serious asthma attacks over 52 weeks. The trial was terminated ear…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:03 UTC